UTHR
UTHR
US91307C1027
United Therapeutics Corporation
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
23.55B EUR
23.12B EUR
25B EUR
21.27B EUR
Enterprise Value
20.19B EUR
21.32B EUR
23.72B EUR
19.71B EUR
Valuation Multiples
Trailing P/E
19.67x
17.64x
19.42x
21x
Forward P/E
18.06x
--
--
--
Price to Sales
7.47x
7.33x
7.89x
8.9x
Price to Book
3.66x
3.61x
4.24x
3x
EV/Revenue
6.4x
6.76x
7.48x
8.25x
EV/EBITDA
13.49x
12.71x
13.66x
14.15x
Price to FCF (P/FCF)
42.28x
21.26x
24.72x
32.77x
EV/FCF
36.24x
19.6x
23.45x
30.37x
FCF Yield
2.37%
4.7%
4.05%
3.05%
ende